ALK and EGFR Mutation Analysis in a Phase II Trial of Cisplatin/Pemetrexed in Japanese Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Annals of Oncology ◽

10.1016/s0923-7534(20)33869-2 ◽

2012 ◽

Vol 23 ◽

pp. ix418

Author(s):

N. Yanagitani ◽

K. Kaburaki ◽

F. Ohyanagi ◽

K. Kudo ◽

A. Horiike ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Mutation Analysis ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Japanese Patients ◽

Small Cell Lung

Download Full-text

401P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of Oncology ◽

10.1016/j.annonc.2020.10.395 ◽

2020 ◽

Vol 31 ◽

pp. S1399-S1400

Author(s):

S. Igawa ◽

R. Noro ◽

K. Kubota ◽

K. Naoki ◽

A. Bessho ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

Phase II Study of Erlotinib in Japanese Patients with Pretreated EGFR Mutation Positive Non-Small Cell Lung Cancer: Lung Oncology Group in Kyushu, Japan (LOGIK0803)

Annals of Oncology ◽

10.1016/s0923-7534(20)33802-3 ◽

2012 ◽

Vol 23 ◽

pp. ix438

Author(s):

K. Takayama ◽

Y. Nakanishi ◽

S. Kawakami ◽

K. Saruwatari ◽

K. Yamada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Study ◽

Japanese Patients ◽

Oncology Group ◽

Small Cell Lung

Download Full-text

Phase II trial of bevacizumab, cisplatin, and pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e19135 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e19135-e19135

Author(s):

Noriko Yanagitani ◽

Fumiyoshi Ohyanagi ◽

Hironari Nishizawa ◽

Hiroshi Gyotoku ◽

Takeshi Uenami ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Japanese Patients ◽

Small Cell Lung

Download Full-text

A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2740-9 ◽

2015 ◽

Vol 75 (6) ◽

pp. 1229-1236 ◽

Author(s):

Moon Ki Choi ◽

Jung Yong Hong ◽

Won Jin Chang ◽

Moon Jin Kim ◽

Sung Min Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Egfr Mutations ◽

Small Cell Lung ◽

Pretreated Patients

Download Full-text

A phase II trial of induction Erlotinib followed by chemotherapy with Platinum + Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e19039 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e19039-e19039

Author(s):

Tetsuo Tani ◽

Kenzo Soejima ◽

Katsuhiko Naoki ◽

Daisuke Arai ◽

Kouta Ishioka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

1365P A prospective, phase II trial of low-dose afatinib monotherapy for patients with EGFR, mutation-positive, non-small cell lung cancer (TORG1632)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1679 ◽

2020 ◽

Vol 31 ◽

pp. S872-S873

Author(s):

R. Noro ◽

S. Igawa ◽

A. Bessho ◽

T. Hirose ◽

S. Tsuneo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Low Dose ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Prospective Phase

Download Full-text

P1.14-36 Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1187 ◽

2019 ◽

Vol 14 (10) ◽

pp. S568

Author(s):

R. Ko ◽

S. Oizumi ◽

H. Mizugaki ◽

Y. Fujita ◽

T. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Cancer Investigation ◽

10.1080/07357900801944856 ◽

2009 ◽

pp. 1-1

Author(s):

A. R. Jazieh ◽

R. Komrokji ◽

A. Gupta ◽

S. Patil ◽

D. Flora ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung

Download Full-text

P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.875 ◽

2021 ◽

Vol 16 (3) ◽

pp. S501

Author(s):

P. Deng ◽

H. Yang ◽

C. Chen ◽

C. Hu ◽

L. Cao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Line Treatment ◽

Small Cell Lung ◽

Extensive Stage

Download Full-text

OA01.06 DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.237 ◽

2018 ◽

Vol 13 (10) ◽

pp. S320-S321 ◽

Author(s):

S. Lin ◽

X. Lin ◽

D. Clay ◽

L. Yao ◽

I. Mok ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Chemoradiation Therapy ◽

Small Cell Lung

Download Full-text